TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16873380

Group type: EXPERIMENTAL
Intervention: 40 mg methylprednisolone
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 80 mg methylprednisolone
Number of subjects: 120

Group type: COMPARATOR
Intervention: Comparison of 40 mg and 80 mg doses
Number of subjects: 120
Study: 16271643

Group type: EXPERIMENTAL
Intervention: Metoprolol (up to 15 mg intravenous then 200 mg oral daily; n=22,929)
Number of subjects: 45852

Group type: COMPARATOR
Intervention: Placebo (n=22,923)
Number of subjects: 45852
Study: 11907616

Group type: EXPERIMENTAL
Intervention: Probucol
Number of subjects: 317

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 317
Study: 10453854

Group type: EXPERIMENTAL
Intervention: 70%/30% heliox
Number of subjects: 23

Group type: COMPARATOR
Intervention: 30% oxygen
Number of subjects: 23
Study: 7869554

Group type: EXPERIMENTAL
Intervention: PRP-OMP
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: HbOC
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Serial combinations of PRP-OMP and HbOC
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Unconjugated PRP
Number of subjects: 497

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 497
Study: 2404480

Group type: EXPERIMENTAL
Intervention: Doxycycline, 100 mg/d for 14 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 334227

Group type: EXPERIMENTAL
Intervention: Nomifensine (50-200 mg daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Amitriptyline (50-225 mg daily)
Number of subjects: 24
Study: 30770291

Group type: EXPERIMENTAL
Intervention: Stereotactic ablative body radiotherapy (SABR) - 54 Gy in three 18 Gy fractions or 48 Gy in four 12 Gy fractions if the tumor was <2 cm from the chest wall.
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard radiotherapy - 66 Gy in 33 daily 2 Gy fractions or 50 Gy in 20 daily 2.5 Gy fractions, depending on institutional preference.
Number of subjects: 101
Study: 28017642

Group type: EXPERIMENTAL
Intervention: Intramuscular Ebola vaccine at 4·0×1010 viral particles (low dose)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intramuscular Ebola vaccine at 1·6×1011 viral particles (high dose)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intramuscular Ebola vaccine at 4·0×1010 viral particles (low dose) after boost
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intramuscular Ebola vaccine at 1·6×1011 viral particles (high dose) after boost
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both vaccine groups (low and high dose)
Number of subjects: 120
Study: 26577514

Group type: EXPERIMENTAL
Intervention: Program participation
Number of subjects: 59
Study: 24036915

Group type: EXPERIMENTAL
Intervention: Visual stimuli designed to elicit variable V1 response spread, details on dosage and duration not available.
Number of subjects: 0
Study: 22078490

Group type: EXPERIMENTAL
Intervention: Structured motivational intervention including smoking cessation advice and spirometry information
Number of subjects: 600

Group type: COMPARATOR
Intervention: Usual clinical practice (control group)
Number of subjects: 600
Study: 18830816

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 9444

Group type: EXPERIMENTAL
Intervention: Chemotherapy + Tamoxifen
Number of subjects: 9444

Group type: COMPARATOR
Intervention: Surgery only
Number of subjects: 9444

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 9444
Study: 18323331

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS) 200 microg, twice daily (BID)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 0
Study: 15482038

Group type: EXPERIMENTAL
Intervention: Eight relapse-prevention booklets mailed over 1 year
Number of subjects: 431

Group type: COMPARATOR
Intervention: Single relapse-prevention booklet mailed over 1 year
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: High-content interventions (eight booklets)
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Frequency of contact (not specified)
Number of subjects: 431
Study: 11536065

Group type: EXPERIMENTAL
Intervention: anterior rhinomanometry (aR)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: impulse-oscillometric rhinometry (IOS)
Number of subjects: 17
Study: 9622116

Group type: EXPERIMENTAL
Intervention: Intraoperative blood salvage (IOBS)
Number of subjects: 61
Study: 8172506

Group type: EXPERIMENTAL
Intervention: Quantitative kinematic gait variables
Number of subjects: 17
Study: 3420976

Group type: EXPERIMENTAL
Intervention: HDCV vaccine
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: FBKC vaccine
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: PCEC vaccine
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: PVRV vaccine
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: PDEV vaccine
Number of subjects: 161

Group type: COMPARATOR
Intervention: 2-1-1 schedule
Number of subjects: 161
Study: 29316338

Group type: EXPERIMENTAL
Intervention: VoiceDiab system supporting bolus calculation
Number of subjects: 44

Group type: COMPARATOR
Intervention: Unsupported group (patients or caregivers calculated boluses)
Number of subjects: 44
Study: 27211272

Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Number of subjects: 146

Group type: COMPARATOR
Intervention: Best Available Therapy (BAT)
Number of subjects: 146
Study: 24330076

Group type: EXPERIMENTAL
Intervention: Polarized light noncontact dermoscopy (PNCD)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Nonpolarized light contact dermoscopy (NPCD)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional stereomicroscope nailfold capillaroscopy (SNFC)
Number of subjects: 45
Study: 24341101

Group type: EXPERIMENTAL
Intervention: Shuganyiyang Capsule combined with tamsulosin hydrochloride sustained release tablets and prostat tablets
Number of subjects: 80

Group type: COMPARATOR
Intervention: tamsulosin hydrochloride and prostat only
Number of subjects: 80
Study: 21176233

Group type: EXPERIMENTAL
Intervention: Assessment and personalised feedback via computer (e-SBI)
Number of subjects: 7

Group type: COMPARATOR
Intervention: No further contact until follow-up (control)
Number of subjects: 7
Study: 17676392

Group type: EXPERIMENTAL
Intervention: Neurolytic celiac plexus block (NCPB) guided by computerized tomography (CT)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Pharmacological therapy
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Neurolytic celiac plexus block (NCPB)
Number of subjects: 56
Study: 16080273

Group type: EXPERIMENTAL
Intervention: rizatriptan capsule preparation (test)
Number of subjects: 20

Group type: COMPARATOR
Intervention: rizatriptan tablet (reference)
Number of subjects: 20
Study: 12512986

Group type: EXPERIMENTAL
Intervention: Professional Crest Whitestrips (6.5% hydrogen peroxide), total contact time 21 hours
Number of subjects: 69

Group type: COMPARATOR
Intervention: Nite White Excel2 (custom tray-based system using hydrogen and carbamide peroxide, 10% carbamide peroxide equivalent), total contact time 28 hours
Number of subjects: 69
Study: 10342501

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 540)
Number of subjects: 1062

Group type: COMPARATOR
Intervention: Control group (n = 522)
Number of subjects: 1062

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1062
Study: 8949806

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg kg‐1 with thiopentone 5 mg kg‐1
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg kg‐1 with propofol 2.5 mg kg‐1
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg kg‐1 with propofol 2.5 mg kg‐1 and alfentanil 20 micrograms kg‐1
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg kg‐1 with thiopentone 5 mg kg‐1 and alfentanil 20 micrograms kg‐1
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group: Thiopentone followed by suxamethonium
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Rocuronium without alfentanil
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Propofol with alfentanil
Number of subjects: 100
Study: 1921398

Group type: EXPERIMENTAL
Intervention: Combined application of hyperthermia and intra-hepato-arterial (IHA) chemotherapy with cisplatinum and 5-fluorouracil
Number of subjects: 14

Group type: COMPARATOR
Intervention: IHA chemotherapy with the same chemotherapeutic regimen
Number of subjects: 14
Study: 10256780

Group type: EXPERIMENTAL
Intervention: Individual instruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group instruction
Number of subjects: 0
Study: 30638439

Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR) training on 1 extremity
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR) training
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR) training on nontourniquet extremity
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26
Study: 29800214

Group type: EXPERIMENTAL
Intervention: Advanced adenoma (≥1 cm, high-grade dysplasia, or tubulovillous or villous histology)
Number of subjects: 15935

Group type: EXPERIMENTAL
Intervention: Nonadvanced adenoma (<1 cm without advanced histology)
Number of subjects: 15935

Group type: COMPARATOR
Intervention: No adenoma
Number of subjects: 15935

Group type: EXPERIMENTAL
Intervention: Advanced adenoma
Number of subjects: 15935

Group type: EXPERIMENTAL
Intervention: Nonadvanced adenoma
Number of subjects: 15935
Study: 26638219

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy‐Adolescent Skills Training (IPT‐AST)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Group Counseling (GC)
Number of subjects: 186
Study: 24480179

Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation (PCV)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Volume-controlled ventilation (VCV)
Number of subjects: 60
Study: 22668911

Group type: EXPERIMENTAL
Intervention: Polyglycolic acid (PGA) sutures
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: Skin staples (SS)
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: Nylon sutures
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: Rupture of membranes >12 hours
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: Surgery duration
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: HIV-infected women
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: Time period of observation
Number of subjects: 1100
Study: 19735494

Group type: EXPERIMENTAL
Intervention: Single stimulation of the radial nerve (Radial group)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Dual stimulation technique (Dual group)
Number of subjects: 70
Study: 17514537

Group type: EXPERIMENTAL
Intervention: Treatment 1 (T1): 2,092 kJ/day (500 kcal/day) peanuts for 8 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment 2 (T2): 2,092 kJ/day (500 kcal/day) peanuts for 3 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment 3 (T3): Substitution of 2,092 kJ/day fat with energy from peanuts
Number of subjects: 0
Study: 16813878

Group type: EXPERIMENTAL
Intervention: difluoromethylornithine
Number of subjects: 454

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 454
Study: 14605042

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (ND) 50 mg IM injection on days 1, 15, 29, and 43
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (ND) 50 mg IM injection
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (1 mL of arachis oil)
Number of subjects: 63
Study: 11040170

Group type: EXPERIMENTAL
Intervention: Topical amethocaine gel (4% w/w, 1.5 g applied under occlusion for one hour)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9363140

Group type: EXPERIMENTAL
Intervention: Image-guided percutaneous chest catheters for draining pleural effusions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fibrinolytic agents for promoting drainage of loculated, viscous pleural fluid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chest tube drainage method
Number of subjects: 0
Study: 1430084

Group type: EXPERIMENTAL
Intervention: GH/hMG/hCG
Number of subjects: 26

Group type: COMPARATOR
Intervention: hMG/hCG
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: hMG/hCG or GH/hMG/hCG
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Normal spontaneous pregnancies
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Pharmacological amounts of hMG
Number of subjects: 26
Study: 6476587

Group type: EXPERIMENTAL
Intervention: Atropine sulphate (18 mg nebulized during tidal breathing)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 30166639

Group type: EXPERIMENTAL
Intervention: Glucose-sweetened beverages
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fructose-sweetened beverages
Number of subjects: 24

Group type: COMPARATOR
Intervention: High-fructose corn syrup-sweetened beverages
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Normal-weight participants
Number of subjects: 24
Study: 30680404

Group type: EXPERIMENTAL
Intervention: Flipped classroom combined with case‐based learning (CBL)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Traditional teaching method
Number of subjects: 51
Study: 27169342

Group type: EXPERIMENTAL
Intervention: Targeted education and new sizes of tubes of non-rinse skin cleanser in three clinical areas.
Number of subjects: 5

Group type: COMPARATOR
Intervention: Targeted education only in one clinical area.
Number of subjects: 5

Group type: COMPARATOR
Intervention: No education or new sized tubes in one clinical area.
Number of subjects: 5
Study: 25069747

Group type: EXPERIMENTAL
Intervention: Temozolomide (TMZ) 75 mg/m² for 21 consecutive days followed by a 7-day rest for up to 6 cycles or until progression
Number of subjects: 53

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Temozolomide (TMZ)
Number of subjects: 53
Study: 22372386

Group type: EXPERIMENTAL
Intervention: 1550-nm fractional photothermolysis (FP)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 15% trichloroacetic acid (TCA) peel
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Post-inflammatory hyperpigmentation
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: FP treatment
Number of subjects: 18

Group type: COMPARATOR
Intervention: TCA peeling
Number of subjects: 18
Study: 20570343

Group type: EXPERIMENTAL
Intervention: Targeted intraoperative radiotherapy
Number of subjects: 2232

Group type: COMPARATOR
Intervention: External beam radiotherapy
Number of subjects: 2232
Study: 17913440

Group type: EXPERIMENTAL
Intervention: Standard Education plus Video Education (SE + VE)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard Education (SE)
Number of subjects: 112
Study: 16541716

Group type: EXPERIMENTAL
Intervention: Biofeedback training (BF) with anorectal manometry and surface EMG, four day-by-day sessions.
Number of subjects: 22

Group type: COMPARATOR
Intervention: Traditional treatment (control group).
Number of subjects: 22
Study: 11897923

Group type: EXPERIMENTAL
Intervention: 40 mg valdecoxib
Number of subjects: 0

Group type: COMPARATOR
Intervention: 50 mg rofecoxib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10052485

Group type: EXPERIMENTAL
Intervention: Verapamil SR (360 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Trandolapril (4 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Vera/tran (180 mg verapamil SR and 2 mg trandolapril)
Number of subjects: 11
Study: 7671948

Group type: EXPERIMENTAL
Intervention: partial whey-hydrolysate formula
Number of subjects: 58

Group type: COMPARATOR
Intervention: regular cow's milk formula
Number of subjects: 58
Study: 1787608

Group type: EXPERIMENTAL
Intervention: Fatty suppositories (FS)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Gelatin capsulated suppositories (GCS)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Local anesthesia
Number of subjects: 49

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 49
Study: 7047770

Group type: EXPERIMENTAL
Intervention: Propranolol hydrochloride (average dose, 105 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Clonidine hydrochloride (0.24 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31402471

Group type: EXPERIMENTAL
Intervention: One preoperative autologous blood donation (PAD)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Two preoperative autologous blood donations (PAD)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: BM harvest
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Overall comparison of Hb levels at day +1
Number of subjects: 102
Study: 28637880

Group type: EXPERIMENTAL
Intervention: Closed tunnel CO2 EVH
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Open tunnel CO2 EVH
Number of subjects: 300

Group type: COMPARATOR
Intervention: Open vein harvesting
Number of subjects: 300
Study: 26933841

Group type: EXPERIMENTAL
Intervention: Early deworming at enrollment
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Early deworming in children with positive Ascaris status
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Deworming (timing not specified)
Number of subjects: 250
Study: 24709170

Group type: EXPERIMENTAL
Intervention: Transulnar approach (TUA)
Number of subjects: 535

Group type: COMPARATOR
Intervention: Transradial approach (TRA)
Number of subjects: 535
Study: 23071207

Group type: EXPERIMENTAL
Intervention: School-Wide Positive Behavioral Interventions and Supports (SWPBIS)
Number of subjects: 12344

Group type: EXPERIMENTAL
Intervention: SWPBIS
Number of subjects: 12344
Study: 19237632

Group type: EXPERIMENTAL
Intervention: Denosumab (subcutaneous 180 mg every 4 weeks or every 12 weeks)
Number of subjects: 111

Group type: COMPARATOR
Intervention: IV Bisphosphonates (IV BP) every 4 weeks
Number of subjects: 111
Study: 17279340

Group type: EXPERIMENTAL
Intervention: Peer rejection (lowest total 'likeability' score)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Peer success (highest score)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control peer evaluation condition
Number of subjects: 142
Study: 16053664

Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel (80 mg/m² i.v. weekly for 6 weeks) + celecoxib (400 mg p.o. b.i.d. continuously)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel + celecoxib
Number of subjects: 58
Study: 11988252

Group type: EXPERIMENTAL
Intervention: Alcohol-based hand gels
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hand rinses
Number of subjects: 0
Study: 9696223

Group type: EXPERIMENTAL
Intervention: Intraperitoneal subdiaphragmatic 0.5% lidocaine and trocar site infiltration of 0.5% bupivacaine
Number of subjects: 61

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 61
Study: 7988858

Group type: EXPERIMENTAL
Intervention: Delivery chair
Number of subjects: 140

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 140
Study: 2656936

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1,000 mg of calcium carbonate daily for three months)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (for three months)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 33
Study: 31004462

Group type: EXPERIMENTAL
Intervention: +SS (SPF-50 sunscreen)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: +SW (simulated sweat)
Number of subjects: 27

Group type: COMPARATOR
Intervention: UVR only
Number of subjects: 27

Group type: COMPARATOR
Intervention: CON (non-exposed control)
Number of subjects: 27
Study: 29025850

Group type: EXPERIMENTAL
Intervention: 1 g of tranexamic acid (TXA) intravenously
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (0.9% saline) intravenously
Number of subjects: 58
Study: 25492264

Group type: EXPERIMENTAL
Intervention: Culturally Enhanced Videofeedback Engagement (CEVE) intervention
Number of subjects: 19

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 19
Study: 22645023

Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus delbrueckii subsp. bulgaricus 8481), 3 capsules per day for 6 months
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 22046862

Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Phenylephrine
Number of subjects: 80
Study: 19609623

Group type: EXPERIMENTAL
Intervention: Electronic discharge summary (EDS)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Conventional dictated discharge summaries
Number of subjects: 209
Study: 16469992

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) at doses of 1.35, 2.7, or 4.05 g/d for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (corn oil)
Number of subjects: 0
Study: 15592577

Group type: EXPERIMENTAL
Intervention: Monteplase followed by PCI
Number of subjects: 0

Group type: COMPARATOR
Intervention: Direct PCI without monteplase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monteplase + PCI
Number of subjects: 0
Study: 15483809

Group type: EXPERIMENTAL
Intervention: Sequential method including individual pressurization of each anchorage hole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional pressurizer
Number of subjects: 0
Study: 10027359

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendicectomy
Number of subjects: 500

Group type: COMPARATOR
Intervention: Open appendicectomy
Number of subjects: 500
Study: 7850048

Group type: EXPERIMENTAL
Intervention: 2 g cefoxitin intravenously (n = 78)
Number of subjects: 153

Group type: COMPARATOR
Intervention: No prophylaxis (n = 75)
Number of subjects: 153
Study: 2390921

Group type: EXPERIMENTAL
Intervention: Billroth II anastomosis
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Roux-en-Y anastomosis
Number of subjects: 22

Group type: COMPARATOR
Intervention: Both Billroth II and Roux-en-Y anastomosis
Number of subjects: 22
Study: 489517

Group type: EXPERIMENTAL
Intervention: Thioridazine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 40